Late-stage human trials showed that AstraZeneca’s antibody drug reduced the risk of developing symptomatic COVID-19 by 77 percent.
Health experts say the vast majority of the hospitalised and dead have been unvaccinated
The FDA said children that are part of the clinical trials "should be monitored for at least two months for side effects."
They are also 4.5 times more likely than the fully vaccinated to get infected and over 10 times more likely to be hospitalized.
In the US, anyone 12 and older is eligible for the vaccine but with the new variants and schools reopening, parents are wondering when younger children can get the shots.
Public health experts hope the change will convince more unvaccinated people to get the shot and spur more employers to require vaccinations.
Aduhelm is a $56,000-a-year drug that is supposed to slows down the brain-destroying disease.
PFAS chemicals are an issue of increasing concern for lawmakers who are working to regulate their use in consumer products.
Emails obtained through the US Freedom of Information Act showed that American officials prepared a note for John Kerry, a top envoy of President Joe Biden, ahead of his meeting with India's Commerce Minister Piyush Goyal
Moderna and Johnson & Johnson are also conducting trials of its vaccine in teens and younger children as well.
The FDA said J&J's vaccine offers strong protection against serious illness, hospitalisations, and death. The company has said it expects to deliver 20 million doses to the US by the end of March
The WHO and FDA are looking to the global flu vaccine system to make decisions around the COVID-19 shots.
Pfizer vaccine roll out in 'less than 24 hrs', says Donald Trump after US FDA approves emergency use
In a video statement released on Twitter, Trump also said that the vaccine would be free for all Americans
Initial doses are scarce and rationed as the US joins Britain and several other countries in scrambling to vaccinate as many people as possible
Donald Trump signs ‘America First’ COVID-19 vaccine executive order, says FDA approval expected soon
As per a senior administration official, the order would restrict the federal government from delivering doses to other nations until there supply outstrips domestic demand
The FDA, however, also said that more research was needed to confirm evidence that the vaccine prevents even the worst cases of COVID-19, offers protection after the first of two doses and that the vaccine works for people who have previously been infected by the virus
Pfizer, BioNTech seek emergency use of COVID-19 shots in US, but vaccine still months away, say experts
Friday’s filing sets off a chain of events as the US FDA and its independent advisers debate if the shots are ready. If so, still the CDC will have to decide how the initial limited supplies are rationed out to anxiously awaiting Americans
The FDA issued emergency use authorization for Eli Lilly’s monoclonal antibody while Regeneron is still awaiting the FDA’s green light for its antibody treatment.
The move indicates the US government’s confidence in the drug's safe and effective use in treating hospitalized COVID-19 patients.
Moderna, Pfizer publish COVID-19 vaccine trial blueprints amid criticism of Donald Trump's response to pandemic
The disclosures are aimed at addressing growing suspicion that Trump’s drive to produce COVID-19 vaccine before the presidential election could result in a product that was unsafe